Metraipolis › archive › dc_68f888e56cbb

Pathophysiological and therapeutic implications of C-type natriuretic peptide/cyclic GMP signaling in pulmonary fibrosis — Europe PMC PMID:41499484

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41499484
DOI
10.1172/jci.insight.196812
License (as archived)
solo-consultazione
Archived
2026-11-07T00:43:46.230Z
SHA-256 of the archived text
6b54dd1421c16a0a46176be012b2c66100b710558da604085dbd1bfcd204278e
Stable URL of this page
https://metraipolis.com/documento/dc_68f888e56cbb

How to cite

Pathophysiological and therapeutic implications of C-type natriuretic peptide/cyclic GMP signaling in pulmonary fibrosis — Europe PMC PMID:41499484 — Europe PMC (en), https://europepmc.org/article/MED/41499484 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_68f888e56cbb (Metraipolis archive dc_68f888e56cbb, sha256 6b54dd1421c16a0a46176be012b2c66100b710558da604085dbd1bfcd204278e)
BibTeX
@misc{dc68f888e56cbb,
  title = {Pathophysiological and therapeutic implications of C-type natriuretic peptide/cyclic GMP signaling in pulmonary fibrosis — Europe PMC PMID:41499484},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41499484},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_68f888e56cbb; sha256 6b54dd1421c16a0a46176be012b2c66100b710558da604085dbd1bfcd204278e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41499484. Agents can read the archived copy with the MCP tool read_document.